Diplomacyindia.com


Experimental antiviral drug effective against Covid : Study

Experimental antiviral drug effective against Covid : Study
April 19
09:13 2021

New York, April 18 (IANS) An experimental oral antiviral drug has shown potential in prevention and treatment of SARS-CoV-2, the virus causing Covid-19 infections, say researchers.

The antiviral — MK-4482 — significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from the US National Institutes of Health scientists. MK-4482 is currently undergoing human clinical trials.

In the study, published in the journal Nature Communications, the scientists found MK-4482 treatment effective when provided up to 12 hours before or 12 hours after infecting the hamsters with SARS-CoV-2.

MK-4482 treatment potentially could mitigate high-risk exposures to SARS-CoV-2, and might be used to treat established SARS-CoV-2 infection alone or possibly in combination with other agents, said Heinz Feldmann and team from the NIH.

The project involved three groups of hamsters: a pre-infection treatment group; a post-infection treatment group; and an untreated control group.

For the two treatment groups, scientists administered MK-4482 orally every 12 hours for three days. At the end of the study, the animals in each of the treatment groups had 100 times less infectious virus in their lungs than the control group. Animals in the two treatment groups also had significantly fewer lesions in the lungs than the control group.

The scientists determined the MK-4482 treatment doses for this study based on previous experiments performed in mouse models of SARS-CoV-1 and MERS-CoV. In those studies, MK-4482 was effective at stopping the viruses from replicating.

Emory University’s Drug Innovation Ventures group in Atlanta developed MK-4482 (also known as molnupiravir and EIDD-2801) to treat influenza. MK-4482 is being developed by biotechnology firm Ridgeback Biotherapeutics in collaboration with Merck as a potential Covid-19 treatment. The drug is in Phase 2 and 3 human clinical studies.

Related Articles

0 Comments

No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment

Your email address will not be published.
Required fields are marked *

Social Icons

Video Interview with Vinod Daniel, CEO, India Vision Institute, Board Member, International Council of Museums & Chairman, Ausheritage

Slovenia Ambassador Marjan Cencen in conversation with Ameya Sathaye, Editor-in-chief Sarkaritel.com on his visit to Hyderabad to coronavirus vaccine facility on a invitation from Ministry of External Affairs, Government of India

DENMARK AMBASSADOR FREDDY SAVNE VISIT TO CORONOVIRUS VACCINE FACILITY AT HYDERABAD, A TRIP ORGANISED BY MINISTRY OF EXTERNAL AFFAIRS, GOVT OF INDIA FOR FOREIGN ENVOYS BASED IN INDIA.

MALTA HIGH COMMISSIONER TO INDIA, H.E. REUBEN GAUCI SHARING HIS IMPRESSION ABOUT HIS VISIT TO HYDERABAD : TRIP ORGANISED BY MINISTRY OF EXTERNAL AFFAIRS, GOVERNMENT OF INDIA FOR ENVOYS BASED IN INDIA TO UPDATE ON CORONAVIRUS VACCINE

H.E. Yerlan Alimbayev, Kazakh Ambassador to India speaking about his impressions of trip organised by Indian Foreign Ministry for Envoys based in India to update on coronavirus vaccine developed by Bbharat Biotech and Biological E at Hyderabad

H.E. Mr. Dinesh Bhatia, Ambassador of India to Argentina in conversation with Ameya Sathaye, Editor-in-Chief

ENVOY SPEAKS : H.E. ATUL GOTSURVE AMBASSADOR OF INDIA TO DPR KOREA IN CONVERSATION WITH AMEYA SATHAYE, EDITOR-IN-CHIEF

Sarkaritel.com Video Interview with Amb Pradeep Kapur on US Presidential Elections 2020

AALAMI T.V. PRESENTS:- ‘PERSPECTIVE: U.S.A.’s Presidential Elections: Global Impact’ : PART 1

AALAMI T.V. PRESENTS:- ‘PERSPECTIVE: U.S.A.’s Presidential Elections: Global Impact’ : PART 2

ENVOY SPEAKS : EXCLUSIVE VIDEO CHAT WITH H.E. YERLAN ALIMBAYEV, AMBASSADOR OF KAZAKHSTAN TO INDIA

Diplomacyindia.com Video Interview with Shri Dnyaneshwar M. Mulay Secretary (CPV & OIA), Ministry of External Affairs speaking on an eventful journey of Indian Passport through its serveral phases, fast expanding network of passport seva kendras, evergrowing numbers, citizen centric service & new Initiatives

Diplomacyindia.com Video Interview with Shri Dnyaneshwar M. Mulay Secretary (CPV & OIA), Ministry of External Affairs speaking on safety & security features of the passport documents in an era of digitalisation his cherished moments & milestones as “Passport Man” of India tranforming the entire passport landscape.

Diplomacyindia.com Video Interview : Mrs. Reva Ganguly Das (IFS) Director General, Indian Council of Cultural Relations Speaking on Yoga Day Celebrations

Exclusive Interview to Diplomacyindia.com with Shri Upendra Tripathi, IAS Interim DG, International Solar Alliance (ISA) speaking on the journey of ISA so far, guiding principles, vision & priority areas & programmes for ISA.

Exclusive Interview to Diplomacyindia.com with Shri Upendra Tripathi, IAS Interim DG, International Solar Alliance (ISA) speaking on expanding rank of international solar alliance & opening the membership to the countries beyond tropics.

Diplomacyindia.com Exclusive Interview with Ambassador of Slovenia to India, H.E. Mr. Jozef Drofenik speaking on Bilateral Relations and Trade between India and Slovenia

Diplomacyindia.com Exclusive Interview with Ambassador of Slovenia to India, H. E. Mr. Jozef Drofenik speaking on Tourism in Slovenia

Pictures of Formal Launch of Website Diplomacyindia.com

Knowledge Partner

Exclusive Interview with Prime Minister of Guyana, H.E. Mr. Moses Veerasammy Nagamootoo during his recent visit to India.Highlights of the interview were Indian Cultural Connect, Vibrant Bilateral Ties and Cultural Connect and India’s Economic Prowess.

Video Message from Shri Prakash Javadekar, MoS (IC) for Forest, Environment & Climate Change on eve of Formal Launch of Website Diplomacyindia.com

Message from Gen. V K Singh, (Retd.) Hon’ble MoS, External Affairs to Diplomacyindia.com

WP2Social Auto Publish Powered By : XYZScripts.com